George Farmer
Stock Analyst at Scotiabank
(2.22)
# 2,796
Out of 5,122 analysts
70
Total ratings
44.74%
Success rate
-0.54%
Average return
Main Sectors:
Top Industries:
Stocks Rated by George Farmer
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| BMEA Biomea Fusion | Maintains: Sector Outperform | $30 → $10 | $1.22 | +719.67% | 4 | Aug 6, 2025 | |
| ACLX Arcellx | Maintains: Sector Outperform | $93 → $133 | $63.57 | +109.22% | 4 | Jul 31, 2025 | |
| INMB INmune Bio | Downgrades: Sector Underperform | $23 → $0.6 | $1.60 | -62.50% | 3 | Jul 1, 2025 | |
| URGN UroGen Pharma | Maintains: Sector Outperform | $23 → $47 | $23.17 | +102.85% | 1 | Jun 13, 2025 | |
| SNDX Syndax Pharmaceuticals | Maintains: Sector Perform | $16 → $17 | $20.74 | -18.03% | 4 | May 6, 2025 | |
| TARA Protara Therapeutics | Initiates: Sector Outperform | $12 | $5.25 | +128.57% | 1 | Apr 16, 2025 | |
| TPST Tempest Therapeutics | Downgrades: Sector Perform | $91 → $9 | $2.84 | +216.90% | 4 | Apr 10, 2025 | |
| JANX Janux Therapeutics | Maintains: Sector Perform | $62 → $41 | $13.83 | +196.46% | 4 | Feb 28, 2025 | |
| NAMS NewAmsterdam Pharma Company | Maintains: Sector Outperform | $47 → $52 | $34.74 | +49.68% | 4 | Feb 27, 2025 | |
| BMRN BioMarin Pharmaceutical | Maintains: Sector Perform | $78 → $80 | $58.99 | +35.62% | 8 | Feb 20, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Sector Outperform | $244 → $224 | $176.40 | +26.98% | 4 | Feb 13, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Sector Outperform | $102 | $35.32 | +188.79% | 1 | Feb 13, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Sector Perform | $18 → $10 | $10.22 | -2.15% | 2 | Jan 8, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Sector Outperform | $439 → $715 | $837.90 | -14.67% | 5 | Nov 5, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Sector Outperform | $20 → $23 | $5.49 | +318.94% | 2 | Oct 18, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Sector Outperform | $20 | $0.73 | +2,651.03% | 1 | Sep 30, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Sector Outperform | $70 → $76 | $21.53 | +253.00% | 4 | Aug 12, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Sector Outperform | $13 | $3.49 | +272.49% | 1 | Mar 14, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Market Perform | $109 | $30.41 | +258.43% | 3 | Nov 17, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Market Perform | $94 → $87 | $98.91 | -12.04% | 5 | Nov 6, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | $33 | $1.96 | +1,583.67% | 1 | Oct 27, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | $40 | $0.51 | +7,740.06% | 1 | Jul 20, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Market Perform | $20 → $27 | $44.04 | -38.69% | 3 | May 6, 2020 |
Biomea Fusion
Aug 6, 2025
Maintains: Sector Outperform
Price Target: $30 → $10
Current: $1.22
Upside: +719.67%
Arcellx
Jul 31, 2025
Maintains: Sector Outperform
Price Target: $93 → $133
Current: $63.57
Upside: +109.22%
INmune Bio
Jul 1, 2025
Downgrades: Sector Underperform
Price Target: $23 → $0.6
Current: $1.60
Upside: -62.50%
UroGen Pharma
Jun 13, 2025
Maintains: Sector Outperform
Price Target: $23 → $47
Current: $23.17
Upside: +102.85%
Syndax Pharmaceuticals
May 6, 2025
Maintains: Sector Perform
Price Target: $16 → $17
Current: $20.74
Upside: -18.03%
Protara Therapeutics
Apr 16, 2025
Initiates: Sector Outperform
Price Target: $12
Current: $5.25
Upside: +128.57%
Tempest Therapeutics
Apr 10, 2025
Downgrades: Sector Perform
Price Target: $91 → $9
Current: $2.84
Upside: +216.90%
Janux Therapeutics
Feb 28, 2025
Maintains: Sector Perform
Price Target: $62 → $41
Current: $13.83
Upside: +196.46%
NewAmsterdam Pharma Company
Feb 27, 2025
Maintains: Sector Outperform
Price Target: $47 → $52
Current: $34.74
Upside: +49.68%
BioMarin Pharmaceutical
Feb 20, 2025
Maintains: Sector Perform
Price Target: $78 → $80
Current: $58.99
Upside: +35.62%
Feb 13, 2025
Maintains: Sector Outperform
Price Target: $244 → $224
Current: $176.40
Upside: +26.98%
Feb 13, 2025
Initiates: Sector Outperform
Price Target: $102
Current: $35.32
Upside: +188.79%
Jan 8, 2025
Maintains: Sector Perform
Price Target: $18 → $10
Current: $10.22
Upside: -2.15%
Nov 5, 2024
Upgrades: Sector Outperform
Price Target: $439 → $715
Current: $837.90
Upside: -14.67%
Oct 18, 2024
Maintains: Sector Outperform
Price Target: $20 → $23
Current: $5.49
Upside: +318.94%
Sep 30, 2024
Initiates: Sector Outperform
Price Target: $20
Current: $0.73
Upside: +2,651.03%
Aug 12, 2024
Maintains: Sector Outperform
Price Target: $70 → $76
Current: $21.53
Upside: +253.00%
Mar 14, 2024
Initiates: Sector Outperform
Price Target: $13
Current: $3.49
Upside: +272.49%
Nov 17, 2020
Downgrades: Market Perform
Price Target: $109
Current: $30.41
Upside: +258.43%
Nov 6, 2020
Maintains: Market Perform
Price Target: $94 → $87
Current: $98.91
Upside: -12.04%
Oct 27, 2020
Initiates: Outperform
Price Target: $33
Current: $1.96
Upside: +1,583.67%
Jul 20, 2020
Initiates: Outperform
Price Target: $40
Current: $0.51
Upside: +7,740.06%
May 6, 2020
Maintains: Market Perform
Price Target: $20 → $27
Current: $44.04
Upside: -38.69%